Company Quick10K Filing
Nemus Bioscience
S-1 2020-07-13 Public Filing
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-23
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-09
S-1 2019-06-04 Public Filing
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-14
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-10
10-Q 2018-03-31 Filed 2018-05-15
S-1 2018-03-23 Public Filing
10-K 2017-12-31 Filed 2018-03-19
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-10
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-21
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-09-15
10-Q 2014-04-30 Filed 2014-06-05
10-Q 2014-01-31 Filed 2014-03-17
10-K 2013-10-31 Filed 2014-01-27
10-Q 2013-07-31 Filed 2013-09-16
10-Q 2013-04-30 Filed 2013-06-27
8-K 2020-08-07 Officers, Other Events, Exhibits
8-K 2020-07-31 Enter Agreement, Other Events, Exhibits
8-K 2020-06-17
8-K 2020-04-29
8-K 2019-12-17
8-K 2019-11-21
8-K 2019-11-19
8-K 2019-08-23
8-K 2019-08-21
8-K 2019-08-07
8-K 2019-05-24
8-K 2019-03-29
8-K 2019-03-25
8-K 2019-02-26
8-K 2019-02-01
8-K 2018-11-14
8-K 2018-11-01
8-K 2018-10-05
8-K 2018-07-31
8-K 2018-06-01
8-K 2018-04-30
8-K 2018-02-16
8-K 2018-02-13
8-K 2018-01-19
8-K 2017-12-28

Nemus Bioscience Financials

NMUS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Portage Biotech (PTGEF) 119,437 0% 173,715 25,158 0 0 0 0 113,271
Nuzee (NUZE) 117,875 16% -10.0 -232% 5,251 1,135 1,794 295 -12,176 -11,718 116,706
Invesco DB Base Metals Fund (DBB) 117,360 -27.0 -3% 129,674 11,075 0 0 -4,521 -4,348 117,360
Security Federal (SFDL) 111,925 5.4 1% 991,261 898,959 0 0 7,742 18,302 98,131
ATIF Holdings (ATIF) 110,483 0% 12,343 1,141 0 0 0 0 104,023
Sears Holdings (SHLD) 110,090 19% -3.7 -5% 33,110,000 35,625,000 13,191,000 2,568,000 -1,700,000 -611,000 2,291,090
CSB Bancorp (CSBB) 109,694 2.0 1% 786,792 703,178 0 0 10,313 15,275 30,125
Nemus Bioscience (NMUS) 108,999 -34.9 -220% 1,725 18,127 0 0 -3,800 -3,087 107,675
Eagle Financial Services (EFSI) 108,359 5.2 1% 851,419 756,789 0 0 9,009 13,416 69,203
UTG (UTGN) 106,601 0% 4.4 3% 418,871 289,863 35,179 0 13,535 18,338 80,872
Consumer Capital Group (CCGN) 106,115 100% -60.0 -140% 1,266 7,930 228 228 -1,772 -1,767 106,047
Bay Banks of Virginia (BAYK) 104,674 3.9 0% 1,112,219 987,362 0 0 5,056 18,746 73,361
Epsilon Energy (EPSN) 103,584 0% 8.7 7% 95,010 19,649 11,983 0 6,665 9,734 84,837
Juniata Valley Financial (JUVF) 102,429 13.6 1% 667,107 593,321 0 0 5,568 9,850 134,126
F&M Bank (FMBM) 102,135 16.1 0% 813,237 722,344 0 0 2,734 8,653 139,285
Invesco CurrencyShares Australian Dollar Trust (FXA) 100,780 0% -56.1 1% 97,821 32 1,223 0 788 788 -44,220
Zoned Properties (ZDPY) 100,699 0% 277.2 0% 8,204 2,225 941 0 7 368 102,125
Virginia National Bankshares (VABK) 99,658 7.1 1% 660,790 585,236 0 0 5,258 10,047 71,803
Juniper Pharmaceuticals (JNP) 98,834 41% 49.7 -1% 67,768 19,275 55,610 22,712 -985 1,629 80,918
Hash Labs (HLAB) 98,593 -24.3 -2,247% 181 419 0 0 -4,067 -4,048 98,439

Balance Sheet ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3037524650391,0252071776014,3433,2212,06283232065380109422602,9501,8791,0631,8584,4172,8121,324
Accounts Receivable322925353527
Inventory
PP&E6947474747961221191716132117131075312543332
Assets1341291461411231681,1263484698214,5423,5112,3501,0816923236174843435573,1582,0421,1661,9574,7253,0801,725
Accounts Payable4093882861321251371833872752276799901019912461616873207
Long-Term Debt43
Liabilities6964625449863508028071,6823,5153,0403,3601,3371,7111,7741,8472,2622,4481,3578,91210,28811,32117,51932,58914,72118,127
Stockholders' Equity666583877381776-454-338-861-594-892-2,370-1,615-2,379-2,914-2,879-2,927-3,230-3,570-5,754-8,245-10,155-15,562-27,864-11,641-16,402
Income Statement ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D195323743152343135460812639261897025-6467321688513
SG&A45169796634668731,3137448111,0851,0227766491,2886706739171,2261,0809781,1941,083990
Tax1-1-0010131000000022-2020020
Net Income2-1-54-148-859-2,732-910-2,057-1,183-691-1,685573-945-1,120-1,283-703-480-628-8,214-2,662-2,096-14,77415,905-4,931
Cash Flow ($'000)2013-04-302013-07-312013-10-312014-01-312014-04-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating7-8-438-952-1,762-752-568-1,295-1,114-1,148-1,230-512-663-816-271-67-2,144-1,053-816-1,431-1,605-1,488
Cash Investing5224500-20-1100-10
Cash Financing-41-20491,9911,9387219925,038-84081,132002,3813,74003,99100